Sartorius Stedim Biotech Investor Relations Service

Sartorius Stedim Biotech's investor relations service focuses on maintaining an ongoing, open dialogue with shareholders, potential investors and financial analysts. We strive to ensure the highest possible level of transparency and provide shareholders and the interested general public alike with equal and timely access to information relevant to our share prices.
 

News

Sartorius Stedim Biotech to be included in the SBF 120 index

Aubagne | Goettingen, June 7, 2013 – Sartorius Stedim Biotech (SSB), a leading international supplier for the pharmaceutical and biotech industries, is to be included in the SBF 120 index of Euronext...[mehr]

 Datum 07.06.2013     Kategorie: Sartorius Stedim Biotech

First-quarter figures: SSB Group continues on the growth track

Further growth in order intake and sales revenue[mehr]

 Datum 23.04.2013     Kategorie: Sartorius Stedim Biotech

Dividend Proposal by the Board of Directors

Proposed dividend to increase by 10.0% to €1.10 per share[mehr]

 Datum 28.02.2013     Kategorie: Sartorius Stedim Biotech

New Reporting Format

Fact Sheet on New Reporting Format  (76 KB)

Stock Charts

Conveniently see at one glance the performance of our shares. more

Financial Calendar

July 23, 2013
Publication of first-half figures for 2013

October 2-3, 2013
Large & Midcap Event in Paris, France

October 21, 2013
Publication of nine-month figures for 2013

more

Stock Chart
Key Figures
2012 Ref. Document
Financial Calendar
Press Releases

Petra Kirchhoff

Vice President of Corporate Communications & Investor Relations

Phone: +49.551.308.1686

Contact

Andreas Theisen

Director Investor Relations

Phone: +49.551.308.1668

Contact